Dr. (Brig) S. Viswanath

Dr. (Brig) S. Viswanath

Visiting Consultant 

36 Years of Experience

Medical Oncologist

MBBS, MD, DM

Reg. No.:153389, Tamil Nadu Medical Council

Rela Hospital, Chennai

English, Hindi, Tamil

Consultation Fee ₹ 800

Book an Appointment

About Dr. (Brig) S. Viswanath

  • Dr. (Brig) S. Viswanath is a well-known Medical Oncologist with over 36 years of experience.
  • Dr. Viswanath brings extensive expertise to the field of medical oncology, specializing in gastrointestinal cancers, colorectal cancer, liquid tumors, and head and neck cancers.
  • His clinical practice revolves around providing advanced treatments such as chemotherapy, immunotherapy, and targeted therapy aimed at delivering optimal outcomes for his patients.
  • Dr. Viswanath's educational qualifications include an MBBS from Karnataka Medical College, Hubli, obtained in 1988, followed by an MD in General Medicine from Command Hospital, Airforce, Bangalore in 2000.
  • He earned a DM in Medical Oncology from the Cancer Institute (WIA), Chennai, in 2006.
  • He has enriched his career with international experience at renowned hospitals, contributing significantly to the global oncology community.
  • Dr. Viswanath has received several prestigious awards and medals, including the Shigikara Award from AFLA (Asian Federation of Laryngectomees Association) in 2014.
  • His academic contributions are notable, with publications in peer-reviewed journals like the Indian Journal of Rheumatology and the Journal of Cancer Metasta Treat.
  • He is a reputable member of several organizations, including the Royal College of Surgeons Edinburgh, the Indian Surgical Oncology Society, and the City Surgical Oncologist Group.

Book Your Appointment With Dr. (Brig) S. Viswanath

Get a Treatment Plan Within 1 Hour

Education

  • MBBS, Karnataka Medical College, Hubli, 1988
  • MD in General Medicine, Command Hospital Air Force, Bangalore, 2000
  • DM in Medical Oncology, Cancer Institute (WIA), Chennai, 2006

Past Experience

  • Commandant, Military Hospital, Chennai, 2021
  • Consultant, Medicine & Medical Oncology, Command Hospital (CC), Lucknow, 2020
  • Professor, Senior Advisor, Medicine & Medical Oncology, Command Hospital (CC), Lucknow, 2020
  • Professor, Senior Advisor, Medicine & Medical Oncology, Army Hospital (R&R), 2018
  • Associate Professor, Senior Advisor, Medicine & Medical Oncology, Army Hospital (R&R), 2016
  • Associate Professor, Senior Advisor, Medicine & Medical Oncology, Command Hospital (EC), 2012
  • Assistant Professor, Classified Specialist in Medicine and Medical Oncology, Command Hospital (EC), 2011
  • Assistant Professor, Classified Specialist in Medicine and Medical Oncology, Command Hospital (WC), 2009

Awards

  • Shigikara Award, Asian Federation of Laryngectomees Association (AFLA), 2014

Associations/Membership

  • Royal College of Surgeons Edinburgh
  • Association of Surgeons of India
  • Indian Surgical Oncology Society
  • City Surgical Oncologist Group

Paper Published

  • Singal V K, Viswanath S, Chengappa ANM. Two cases of refractory rheumatoid arthritis treated with Rituximab; Indian Journal of Rheumatology, Vol2, Issue 3,S27:sept 2007.
  • Sundaram V,Sanyal N. Clinicopathological profile of bronchogenic carcinoma in a tertiary care hospital in eastern part of India. Clinical Cancer Investig J 2014;3:220-4.
  • Darling HS, Viswanath S, Rajeev V. T- lymphoblastic lymphoma in an undiagnosed rheumatoid arthritis- A rare occurrence. Indian Journal of Rheumatology,Vol. 10, Issue 1,p48-50, 2015.
  • Viswanath S, Pathak A, Kapoor A, Rathore A, Kapur BN. Changing paradigm in treatment of lung cancer. J Cancer Metasta Treat 2016;2:214-9.
  • Sundaram V. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman’s disease) with systemic involvement. Afr J Med Health Sci 2016;15:62-4.
  • Dubey AP, Viswanath S. A case of metastatic insulinoma: Management and review of literature. OGH Reports, 2016; 5(2):79-81.
  • Viswanath S, Pathak A. Management of HER2-positive breast cancer: A review. J NTR Univ Health Sci 2016;5:87-92.
  • Pathak A, Viswanath S, Rathore A, Dubey AP. Paraneoplastic limbic encephalitis forgotten etiology of altered sensorium. Int J Adv Med 2016;3:771-3.
  • Dubey AP*, Viswanath S, Suhag V, Pathak A, Rathore A, Kapoor A. Oral voriconazole causing severe hypokalemia, acute quadriplegia and prolonged qt interval: a rare case report, wjpmr, 2016, 2(2).
  • Kapoor A, Viswanath S, Ranjan S, Kapur BN. A Clinico demographic Study of Receptor status in Carcinoma Breast. J Carcinog 2016, 15:2(7 April 2016) (ACOS Abstracts):S162.
  • Rajeev V, Kapur A, Viswanath S, Kapur BN. Primary CNS Lymphoma in Immunocompetent Patient – Case Series. J Carcinog 2016, 15:2(7 April 2016) (ACOS Abstracts):S215.
  • Purkayasta A, Sharma N, Viswanath S, Sunitha B. Adenoid Cystic Carcinoma of Lung: A oncological rarity treated with definitive chemoradiation.Int JCancer Ther Oncol.2016; 4(3):4315
  • Purkayastha A, Pathak A, Sharma N, Viswanath S, Dutta V. Primitive neuroectodermal tumor of lungs in adults: a rare series of three cases treated with upfront chemo-radiation. Transl Lung Cancer Res 2016;5(3):350-355.
  • Pathi N, Viswanath S, Pathak A, Rathore A, Prukayasta A. Receptor tyrosine kinase signalling pathways: a review. Int J Adv Med.2016 Oct 26;3(4):783-9.
  • Viswanath S, Bhardwaj R, kapoor A. Clinicopathological significance of epidermal growth factor receptor and vascular endothelial growth factor expression in biliary tract malignancies. J NTR Univ Health Sci 2017;6:82-5.
  • Dubey AP, Vishwanath S, Nikhil P, Rathore A, Pathak A. Microsatellite instability in stage II colorectal cancer: An Indian perspective. Indian J Cancer 2016;53:513-7.
  • Dubey AP,Singh R, Pathak A, Viswanath S, Rathore A, Pathi N. Clinical profile, prognostication and treatment outcomes in non Hodgkin’s lymphoma. Int J Adv Med 2017;4:1184-8.
  • Singh R, Viswanath S, Maleskar D. Clinical profile and outcomes of granulocytic sarcoma among myeloid malignancies treated in a tertiary care center. Clin Cancer Investig J 2017;6:56-61.
  • Carcinoma of the Unknown primary- Knowing the unknown facts. Pathak A, Gupta A, Rathore A, Vishwanath S. World J Pharm Sci2018; 6(1): 40-46.
  • Dubey A P, Vishwanath S, Nikhil P, Rathore A, Pathak A, Kumar R. Microsatellite instability in stage II and III colorectal cancer: Patterns and profile. Indian J Med Paediatr Oncol [serial online] 2018 [cited 2018 Jan 29];39:36-41.
  • Dubey A P, Pathi N, Rathore A, Viswanath S, Pathak A, Sud R, Rai S K. Clinicopathological profile of anaplastic lymphoma kinase-positive non small cell lung cancer: An Indian perspective. Indian J Med Paediatr Oncol [serial online] 2018 [cited 2018 Jan 29];39:32-5.
  • Dubey AP, Rawat K, Pathi N, Viswanath S, Rathore A, Kapoor R, et al. Carcinoma of gall bladder: Demographic and clinicopathological profile in Indian patients. Oncol J India 2018;2:3-6.
  • Purkayasta A, Sharma N, Viswanath S, Sunitha B. Adenoid Cystic Carcinoma of Lung: A oncological rarity treated with definitive chemoradiation..Int J Cancer Ther Oncol.2016; 4(3):4315
  • Incidence of K-RAS mutation in metastatic colorectal carcinoma and further to find any associated correlation between K-RAS mutation and various demographic and clinical factors. A Hospital based study(#652) Altaf Ali 1 , A K Dhar 2 , Bhupender Kapur 2 , Dharmesh Soneji 2 , Amul Kapoor 2 , S Viswanath 2 E Poster 2014 WCC
  • Sharma N, Purkayastha A, Vishwanath S, Jaiswal P. To compare and determine the diagnostic accuracy of [18F]- fluorodeoxyglucose positron emission tomography scan in predicting pathological response in operated carcinoma esophagus patients after initial neoadjuvant chemoradiation and neoadjuvant chemotherapy. World J Nucl Med2018;17:79-85.
  • Dubey A P, Pathi N, Viswanath S, Rathore A, Pathak A, Sud R. New insights into anaplastic lymphoma kinase-positive non small cell lung cancer. Indian J Cancer 2017;54:203-8
  • Rathore A, Ranjan S, Vishwanath S, Pathak A, Dubey A P, Nikhil P. BRCA 1 and 2 mutations in carcinoma breast: An Indian study. Clin Cancer Investig J 2018;7:97-103
  • Darling HS, Viswanath S, Singh Randeep.Medication Related osteonecrosis of Jaw- A medical oncologist’s perspective.International Dental Journal of Student’s Research 2018;6(1):1-6
  • A clinic- epidemiological, pathological and molecular study of lung cancer in Northwestern India. Darling HS, Viswanath S, Singh R, Ranjan S, Pathi N, Rathore A, Pathak A, Sud R. DOI: 10.4103/jcrt.JCRT_473_17
  • Lohia, N., Prashar, M., Singh, S,Bhatnagar S, Viswanath S, Anand S, et al.Epidemiological and survival Trends in patients of Cancer of Uterine Cervix Treated with Definitive Concurrent Chemoradiotherapy: Obsevations from a North Indian Hospital Based Cancer Registry. Indian J Gynecol Oncology (2019) 17: 44
  • Lohia N, Bhatnagar S, Singh S Prasher M, Subramaniam A, Viswanath S, et al. Survival trends in oral cavity cancer patients treated with surgery and adjuvant radiotherapy in a tertiary centre of Northern India. Where do we stand compared to the developed world? SRM J Res Dent Sci 2019,10 26-31.
  • Prasher M, Soneji D, Viswanath S, Singh S. Cardiotoxicity with sequential use of Antharacycline and Transtuzumab in carcinoma breast patients in a North Indian tertiary care centre. J NTR Univ Health Sci 2019, 8: 83-8.
  • Bisht N, Bhatnagar S, Viswanath S,Singh S, Lohia N. A comparative study of two protocols of concurrent chemotherapy with external beam radiotherapy in treatment of locally advanced cervical cancer: Cisplatin versus cisplatin plus capecitabine combination. Indian Journal of Gynecologic Oncology (2021)19:18

Field of Expertise

  • Adrenal Cancer Treatment
  • Bacillus Calmette Guerin (BCG) Therapy
  • Benign and Cancerous Tumor Excision
  • Bile Duct Cancer Treatment
  • Bone Marrow Transplant
  • Brain Tumor Surgery
  • Breast Biopsy
  • CAR T-Cell Therapy
  • Carcinoid Tumor Treatment
  • Castleman Disease Treatment
  • Chemotherapy
  • Colon Cancer Surgery
  • Completion Thyroidectomy
  • Endometrial Cancer Treatment
  • Endoscopic Tumor Removal
  • Ewing Family of Tumors Treatment
  • Fine Needle Aspiration
  • Genitourinary Cancer Treatment
  • Gestational Trophoblastic Disease (GTD) Treatment
  • High-Intensity Focused Ultrasound (HIFU) for Prostate Cancer
  • Hormone Therapy
  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
  • Image-Guided Radiation Therapy (IGRT)
  • Immunotherapy
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Kaposi Sarcoma Treatment
  • Lumpectomy
  • Malignant Mesothelioma Treatment
  • Metastatic Tumor Treatment
  • Minimally Invasive Cancer Surgery
  • Nasal Cavity and Paranasal Sinus Cancer Treatment
  • Nasopharyngeal Cancer Treatment
  • Non-Small Cell Lung Cancer (NSCLC) Treatment
  • Oncological Surgery
  • Papillary Thyroid Cancer Treatment
  • Penile Cancer Treatment
  • PET CT Scan
  • Proton Therapy
  • Radiation Therapy
  • Radioisotope Therapy
  • Rhabdomyosarcoma (RMS) Treatment
  • Robotic Cancer Surgery
  • Skin Lymphoma Treatment
  • Small Intestine Cancer Treatment
  • Targeted Therapy
  • Thymectomy
  • Thymoma and Thymic Carcinoma Treatment
  • Transarterial Chemoembolization (TACE)
  • Vaginal Cancer Treatment
  • Vulvar Cancer Treatment
  • Whipple Procedure
  • Acute Lymphoblastic Leukemia (ALL)
  • Acute Lymphocytic Leukemia
  • Acute Myeloid Leukemia (AML)
  • Acute Promyelocytic Leukemia (APL)
  • Adenocarcinoma
  • Adenosquamous Carcinoma
  • Adrenocortical Carcinoma
  • Adult Hodgkins Lymphoma
  • AIDS-Related Cancer
  • Ameloblastoma
  • Anal Cancer
  • Anaplastic Carcinoma
  • Appendix Cancer
  • Atypical Hyperplasia
  • Atypical Spindle Cell Tumor
  • Atypical Teratoid/Rhabdoid Tumor (ATRT)
  • Bacillus Calmette Guerin (BCG) Treatment for Non-Muscle Invasive Bladder Cancer
  • Basal Cell Carcinoma (BCC)
  • Basal Cell Carcinoma of the Skin
  • Benign Bone Tumors
  • Benign Hematology
  • Benign Lung Tumors
  • Benign Soft Tissue Tumors
  • Bile Duct Cancer, Stones, & Strictures
  • Bladder Cancer
  • Blood Cancer
  • Bone Cancer
  • Bone Marrow Cancer
  • Breast Cancer
  • Breast Cancer During Pregnancy
  • Breast Cancer Recurrence
  • Bronchial Tumors
  • Burkitt Lymphoma
  • Cancer in Children
  • Carcinoid Syndrome
  • Carcinoid Tumor (Gastrointestinal)
  • Carcinoid Tumors of the Lungs
  • Cervical Cancer
  • Childhood Acute Lymphoblastic Leukemia
  • Cholangiocarcinoma
  • Chronic Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelogenous Leukemia
  • Chronic Myeloid Leukemia (CML)
  • Chronic Myeloproliferative Neoplasms
  • Colorectal Cancer
  • Cutaneous T-Cell Lymphoma
  • Cyclic Neutropenia
  • Desmoid Tumor
  • Ductal Carcinoma in Situ (DCIS)
  • Elevated PSA (Prostate-Specific Antigen) Level
  • Embryonal Tumors
  • Eosinophilia
  • Esophageal Cancer
  • Esophagectomy
  • Esthesioneuroblastoma
  • Estrogen Dependent Cancers
  • Ewing Sarcoma
  • Extracranial Germ Cell Tumor
  • Extragonadal Germ Cell Tumor
  • Extrahepatic Bile Duct Cancer
  • Fallopian Tube Cancer
  • Familial Adenomatous Polyposis (FAP)
  • Familial Adenomatous Polyposis (FAP): Inherited
  • Follicular Lymphoma
  • Free Flap Surgery for Treating Osteoradionecrosis
  • Gallbladder Cancer
  • Gastric Cancer
  • Gastrointestinal Stromal Tumor (GIST)
  • Gestational Trophoblastic Disease
  • Giant Cell Tumor
  • Gum Tumor
  • Hairy Cell Leukemia (HCL)
  • Head and Neck Cancer
  • Heart Cancer
  • Hepatocellular Cancer
  • Hereditary Non-polyposis Colorectal Cancer (HNPCC)
  • Hurthle Cell Carcinoma
  • Hypopharyngeal Cancer
  • Hypopharyngeal Cancer
  • Immunotherapy
  • In-situ Breast Cancer
  • Incontinence After Prostate Surgery
  • Inflammatory Breast Cancer
  • Intensity Modulated Radiation Therapy
  • Intraocular Melanoma
  • Invasive Breast Cancer
  • Invasive Lobular Carcinoma
  • Islet Cell Tumor
  • Kaposi Sarcoma
  • Large Cell Carcinoma
  • Large Granular Lymphocytic (LGL) leukemia
  • Leukemia
  • Lip and Oral Cavity Cancer
  • Liver Cancer
  • Liver Cysts & Liver Tumors
  • Lung Cancer
  • Lymphatic Cancer
  • Lymphocytosis
  • Male Breast Cancer
  • Malignant Fibrous Histiocytoma (MFH)
  • Malignant Mesothelioma
  • Malignant Soft Tissue Tumors
  • Mediastinal Tumor
  • Medullary Carcinoma
  • Melanoma
  • Merkel Cell Carcinoma
  • Metastatic Cancer
  • Metastatic Spinal Tumors
  • Metastatic Squamous Neck Cancer with Occult Primary
  • Metastatic Tumors
  • Mouth Cancer
  • Multiple Endocrine Neoplasia (MEN) Syndromes
  • Multiple Myeloma
  • Myelodysplastic Syndromes
  • Nasal Cavity and Paranasal Sinus Cancer
  • Nasopharyngeal Cancer
  • Neuroendocrine Tumor
  • Non-Small Cell Lung Cancer
  • NUT Midline Carcinoma
  • Oncogenic Osteomalacia
  • Ophthalmic Cancer
  • Oral Cancer
  • Oropharyngeal Cancer
  • Osteosarcoma
  • Ovarian Cancer
  • Ovarian Germ Cell Tumors
  • Ovarian Primary Peritoneal Cancer
  • Ovarian Sex Cord Stromal Tumor
  • Pancreatic Cancer
  • Pancreatic Neuroendocrine Tumor
  • Paraganglioma
  • Paraneoplastic Syndromes
  • Parathyroid Cancer
  • Parotid Gland Tumor
  • Pediatric Chordomas
  • Pediatric Ependymoma
  • Pediatric Germ Cell Tumor
  • Pediatric Rhabdomyosarcoma
  • Pediatric Spinal Cord Tumor
  • Pediatric Spinal Tumor
  • Pediatric Vascular Tumors
  • Penile Cancer
  • Pharyngeal Cancer
  • Pheochromocytoma
  • Pigmented Villonodular Synovitis (PVNS)
  • Pineal Region Tumor
  • Plasma Cell Neoplasms
  • Pleural Tumor
  • Pleuropulmonary Blastoma
  • Prostate Cancer
  • PTEN Hamartoma Tumor Syndrome (Cowden Syndrome and Bannayan-Riley-Ruvalcaba Syndrome)
  • Pulmonary Nodules
  • Pure Red Cell Aplasia (PRCA)
  • Rectal Cancer
  • Recurrent Cancer
  • Relapsed ALL
  • Relapsed AML
  • Relapsed Multiple Myeloma
  • Renal Cell Cancer
  • Retinoblastoma (Cancer of the Eye)
  • Retroperitoneal Tumor
  • Rhabdomyosarcoma
  • Salivary Gland Cancer
  • Sarcoma
  • Sezary Syndrome
  • Skin Cancer
  • Skull Base Tumor
  • Small Cell Carcinoma
  • Small Cell Lung Cancer
  • Small Intestine Cancer
  • Soft Tissue Sarcoma
  • Spinal Tumor
  • Squamous Cell Carcinoma (SCC)
  • Stage 4 Cancer
  • Stomach Cancer
  • Sun Exposure & Skin Cancer
  • Synovial Sarcoma
  • Testicular Cancer
  • Throat Cancer
  • Thrombocytosis
  • Thymoma and Thymic Carcinoma
  • Thymus Gland Tumor
  • Thyroid Cancer
  • Tracheobronchial Tumor
  • Transitional Cell Cancer
  • Urethral Cancer
  • Uterine Sarcoma
  • Vaginal Cancer
  • Vascular Tumor
  • Vulvar Cancer
  • Wilms Tumor